ALSE Stock News Alseres Pharmaceutcl (ALSE) 0.0327 07/26/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Alseres Pharmaceutcl (ALSE) 0.0327 $ALSE

Nova Scotia Power Inc. Approves Preferred Share Quarterly Dividend
Business Wire - Fri Jul 04, 9:21AM CDT
On July 4, 2014 the Board of Directors of Nova Scotia Power Inc. (TSX: NSI.PR.D) approved a quarterly dividend of $0.36875 per Nova Scotia Power Incorporated Series D First Preferred Share payable on and after October 15, 2014 to Series D preferred shareholders of record October 1, 2014.

Travelers Capital Corporation Arranges Project Financing for 24 MW Wind Energy Project Portfolio in Nova Scotia
CNW Group - Fri Jun 13, 4:42PM CDT
Travelers Capital Corporation is pleased to announce that it has successfully arranged $57 million of non-recourse project financing for a portfolio of four wind energy projects in Nova Scotia aggregating 24 MW (the "Projects" . The Projects were developed by juwi Wind Canada and sold its minority or majority control in each Project to Firelight Infrastructure Partners prior to construction. The Projects consist of the following:

Travelers Capital Corporation Arranges Project Financing for 28 MW Wind Energy Project in Nova Scotia
CNW Group - Thu May 15, 12:29PM CDT
Travelers Capital Corporation is pleased to announce that it has successfully arranged $61.4 million of non-recourse project financing for a 28 MW wind project in Nova Scotia (the "Project" for SCOTIANWEB LIMITED PARTNERSHIP, a partnership between Scotian Wind Inc. ("SWI" , Scotian WindFields Inc. ("SWFI" and WEB Wind Energy North America Inc. ("WEB N.A." . The Project consists of eight separate wind facilities that will sell 100% of their output to Nova Scotia Power Inc., a wholly-owned subsidiary of Emera Inc., under 20-year power purchase agreements.

Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica

Nova Scotia Power approves preferred share dividend of CAD0.37
M2 - Thu Feb 06, 5:21AM CST
The board of directors of an electric utility company, Nova Scotia Power Inc (TSX:NSI.PR.D), based in Canada, authorised a quarterly dividend of CAD0.37 per share on its series D first preferred share, the company declared on Wednesday.

Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
M2 - Fri Aug 02, 9:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xckkfp/radiopharmaceutica#summary) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured. I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - - France (2) - - Germany (2) - - The United Kingdom (4) - - Italy (2) - - Spain (1) - - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/xc...ca#summary

Nova Scotia Power Inc. Issues $300 Million ofMedium Term Notes
Business Wire - Fri Jul 19, 8:59AM CDT
Today, Nova Scotia Power Inc. completed the issue of $300 million Series Z Medium Term Notes. The Series Z Notes bear interest at the rate of 4.50% and yield 4.537% per annum until July 20, 2043.

Nova Scotia Power's board approves USD0.36875 quarterly preferred share dividend
M2 - Mon Jul 08, 4:26AM CDT
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D) on Friday announced the approval of quarterly dividend of USD0.36875 per Nova Scotia Power Incorporated Series D first preferred share.

Nova Scotia Power announces quarterly dividend of USD0.36875 per share on its preferred stock
M2 - Mon Jul 08, 3:06AM CDT
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D), a provider of electricity generation, transmission and distribution services, authorised series D first preferred stock dividends of USD0.36875 per share, the company declared on Friday.

Nova Scotia Power announces series D preferred dividend of USD0.36875 per share
M2 - Thu Feb 07, 4:36AM CST
The board of directors of Nova Scotia Power Inc (TSX:NSI.PR.D), an electricity provider, has authorised a series D first preferred dividend of USD0.36875 per share for the quarter ending 31 March 2013, the company declared on Wednesday.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 308

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 350

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 272

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 23

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 225

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 246

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 232

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 377

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 156

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading

Top 5 Most Recently Viewed Articles

Coloplast A/S Highlights Impressive Full-Year Performance

Updated Category News Views 231

Coloplast A/S Financial Results Overview Coloplast A/S recently announced its full-year financial results for the fiscal year 2023/24, highlighting a solid performance characterized by growth and resilience across various business sectors. Their latest report demonstrates a robust organic growth rate of 8%, coupled with a notable EBIT margin of 27%. In monetary terms, the...

Continue Reading
Introducing Sproutr’s Innovative Program Placement Services

Updated Category News Views 200

Sproutr Unveils Comprehensive Program Placement Services Sproutr, a leading firm in insurance program design and product development, has launched its innovative Program Placement Services. This new offering aims to streamline the entire process of insurance program development, ensuring that it aligns well from the initial design to the final placement with carriers. The...

Continue Reading
Unstoppable Domains Introduces .DEMOS: Redefining Digital Identity

Updated Category News Views 147

Introducing .DEMOS: A New Era of Digital Identity In an exciting development, Unstoppable Domains has rolled out a new top-level domain, .DEMOS, in collaboration with Kynesys.xyz. This innovative domain is positioned as a Web3-first solution designed to foster connection and collaboration in a borderless internet landscape. The name .DEMOS is derived from the Greek term...

Continue Reading
Investors Urged to Join Class Action Against Open Lending Corporation

Updated Category News Views 193

Open Lending Corporation: A Call to Action for Affected Investors Investors suffering heavy losses in Open Lending Corporation (NASDAQ: LPRO) are presented with the chance to take action. It's an opportunity for those impacted by the recent financial discrepancies and corporate disclosures to become lead plaintiffs in a class action lawsuit. Class Action Lawsuit Details...

Continue Reading
McAfee Revolutionizes Digital Security with AI Techniques

Updated Category News Views 253

Innovative Protection: McAfee Leads in AI-Powered Security Recognized as a leader in online security, McAfee has become synonymous with consumer safety in a rapidly evolving digital landscape. With the escalation of online threats, including sophisticated deepfakes and scams, McAfee's advanced artificial intelligence capabilities make it the prime choice for individuals...

Continue Reading